RECITALSMerger Agreement • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Delaware
EXHIBIT 10.31 CONFIDENTIAL SEPARATION AGREEMENT This Confidential Separation Agreement (the "Agreement") is entered into between Lynx Therapeutics, Inc. (the "Company") and David W. Martin, Jr. ("Dr. Martin"). 1. SEPARATION. Dr. Martin's last day of...Separation Agreement • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.25 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT is made by and between SPECTRAGEN, INC., a Delaware corporation (the "Company"), and SAM ELETR ("Purchaser"). WITNESSETH: WHEREAS, Purchaser holds a non-statutory stock option to...Stock Purchase Agreement • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
EXHIBIT 10.29 JOINT VENTURE AGREEMENT between LYNX Therapeutics Inc., 3832 Bay Center Place, Hayward, California, 94545, USA (hereinafter referred to as "LYNX") and BASF Aktiengesellschaft, 67056 Ludwigshafen, Federal Republic of Germany (hereinafter...Joint Venture Agreement • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
RECITALSTechnology Services Agreement • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
